Gentiva Reports Fourth Quarter and Fiscal 20...(179979 Long-term debt 251...)

Date:2/18/2009

179,979 Long-term debt 251,000 307,696 Deferred tax liabilities, net 64,262 48,572 Other liabilities 17,189 22,557 Shareholders' equity 494,971 323,429 ------- ------- Total liabilities and shareholders' equity $973,497 $882,233 ======== ======== Common shares Outstanding 28,864 28,046 ======== ======== ( A ) The Condensed Balance Sheet as of December 28, 2008 reflects the impact of the CareCentrix transaction in various line items. ( B ) Short-term and long-term investments at December 28, 2008 and December 30, 2007 consisted of AAA-rated auction rate securities. At December 28, 2008, long-term investments were presented net of a $1.9 million valuation allowance, the charge for which was recorded in Shareholders' Equity. ( C ) Accounts receivable, net, included an allowance for doubtful Accounts of $8.2 million and $9.4 million at December 28, 2008 and December 30, 2007, respectively. (in 000's) Fiscal Year ----------- Condensed Statements of Cash Flows 2008 2007 ---------------------------------- ---- ---- OPERATING ACTIVITIES: Net income $153,450 $32,828 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 22,044 20,014 Amortization of debt issuance costs 1,753 1,063 Provision for doubtful accounts 11,
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results